Objectives To assess cost-effectiveness of direct oral anticoagulants (DOACs) compared
with vitamin K antagonists (VKAs) for stroke prevention in atrial fibrillation (AF) by pooling …

BACKGROUND Cryptogenic stroke is a stroke for which no cause is identified after standard
diagnostic tests. Long-term implantable cardiac monitors may be better at diagnosing atrial …

Purpose Direct oral anticoagulant (DOAC) use for the prevention of thromboembolic
complications in patients with non-valvular atrial fibrillation (AF) has increased steadily in …

Background Atrial fibrillation (AF) is a severe epidemiological and public health concern
among the elderly population worldwide, with substantial economic and social burdens …

Background Warfarin use for stroke prevention in atrial fibrillation (AF) patients with chronic
kidney disease is debated. Apixaban was shown to be safer than warfarin, with superior …

Background Rheumatic mitral valve disease (RMVD) is a major cause of acquired valvular
disease in India. We compared the cost-effectiveness of surgical treatment strategies for …

Abstract Introduction Currently, 15–20% of individuals with coronary artery disease (chronic
coronary syndrome [CCS]) or peripheral artery disease (PAD) receiving routine treatment …

The relevant cost-effectiveness study reports economic terms in the currency units of each
country at a certain time unit, so that currency conversion is needed for the standardization …

Atrial fibrillation (AF) is associated with a five-fold increase in the risk of thromboembolic
events (stroke/systemic embolism). When initiated in individuals at risk of a thromboembolic …

Introduction: Digital health interventions, such as electronic audit and feedback (eA &F), are
increasingly used to improve the quality and safety of healthcare. Where there is limited …